Release Date: 07/07/10 10:18 Summary: Appointment of New CEO and Managing Director Price Sensitive: Yes Download Document 28.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%